C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 38/17 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01) C07K 14/47 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2402685
The present invention relates to immunogenic peptides that can be used to elicit an immune response in a human or animal against a tumor, in particular against an immunogenic tumor. The peptides are derived from the G250 tumor antigen that is frequently expressed on immunogenic tumors, such as renal cell carcinoma. The particular peptides are selected for their capability to elicit both CD4+ and CD8+ T-cell responses against cells expressing the G250 antigen.
Adema Gosse Jan
de Vries Ingrid Jolanda Monique
Figdor Carl Gustav
Oosterwijk Egbert
Vissers Joost Lambert Max
Katholieke Universiteit Nijmegen
Ridout & Maybee Llp
LandOfFree
Renal cell carcinoma-antigen g250-derived peptides that... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Renal cell carcinoma-antigen g250-derived peptides that..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Renal cell carcinoma-antigen g250-derived peptides that... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1571520